6F3Y

Backbone structure of Des-Arg10-Kallidin (DAKD) peptide bound to human Bradykinin 1 Receptor (B1R) determined by DNP-enhanced MAS SSNMR

Summary for 6F3Y

• Entry DOI: 10.2210/pdb6f3y/pdb
• Related: 6F27 6F3V 6F3W 6F3X
• NMR Information: BMRB: 34209
• Descriptor: Kininogen-1 (1 entity in total)
• Functional Keywords: gpcr, dnp, membrane protein
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 1
• Total formula weight: 1034.21

Authors

Mao, J.,Kuenze, G.,Joedicke, L.,Meiler, J.,Michel, H.,Glaubitz, C. (deposition date: 2017-11-29, release date: 2018-01-10, Last modification date: 2024-06-19)

Primary citation

Joedicke, L.,Mao, J.,Kuenze, G.,Reinhart, C.,Kalavacherla, T.,Jonker, H.R.A.,Richter, C.,Schwalbe, H.,Meiler, J.,Preu, J.,Michel, H.,Glaubitz, C.
The molecular basis of subtype selectivity of human kinin G-protein-coupled receptors.
Nat. Chem. Biol., 14:284-290, 2018

PubMed Abstract: G-protein-coupled receptors (GPCRs) are the most important signal transducers in higher eukaryotes. Despite considerable progress, the molecular basis of subtype-specific ligand selectivity, especially for peptide receptors, remains unknown. Here, by integrating DNP-enhanced solid-state NMR spectroscopy with advanced molecular modeling and docking, the mechanism of the subtype selectivity of human bradykinin receptors for their peptide agonists has been resolved. The conserved middle segments of the bound peptides show distinct conformations that result in different presentations of their N and C termini toward their receptors. Analysis of the peptide-receptor interfaces reveals that the charged N-terminal residues of the peptides are mainly selected through electrostatic interactions, whereas the C-terminal segments are recognized via both conformations and interactions. The detailed molecular picture obtained by this approach opens a new gateway for exploring the complex conformational and chemical space of peptides and peptide analogs for designing GPCR subtype-selective biochemical tools and drugs.

PubMed: 29334381
DOI: 10.1038/nchembio.2551

Experimental method

SOLID-STATE NMR